Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study

Sequelae symptoms Any of the following symptoms 777/1149 (68{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 583/1188 (49{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

650/1190 (55{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

194/286 (68{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 141 (48{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

158/294 (54{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

509/774 (66{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 395/802 (49{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

440/805 (55{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

74/89 (83{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 47 (52{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

52 (57{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

Fatigue or muscle weakness 593/1151 (52{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 240/1188 (20{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

357/1190 (30{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

143/286 (50{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 60 (20{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

89/294 (30{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

385/776 (50{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 161/802 (20{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

235/805 (29{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

65/89 (73{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 19 (21{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

33 (36{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

Sleep difficulties 313/1151 (27{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 206/1188 (17{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

298/1190 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

75/286 (26{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 47 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

70/294 (24{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

205/776 (26{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 146/802 (18{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

203/805 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

33/89 (37{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 13 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

25 (27{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Hair loss 252/1151 (22{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 131/1188 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

142/1190 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

61/286 (21{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 27 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

41/294 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 169/776 (22{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 97/802 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

88/805 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

22/89 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

13 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Smell disorder 128/1151 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 56/1188 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

67/1190 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

32/286 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 16 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 21/294 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 82/776 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 34/802 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

42/805 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

14/89 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 6 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

Joint pain 126/1147 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 141/1188 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 117/1190 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 40/287 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 33 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 30/294 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 70/772 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 93/802 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 79/805 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 16/88 (18{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 15 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 8 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Palpitations 108/1151 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 110/1188 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 145/1190 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 28/286 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 19 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 41/294 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

66/776 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 84/802 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 95/805 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 14/89 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 9 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Decreased appetite 92/1151 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 34/1188 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

33/1190 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

25/286 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 6 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

10/294 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 56/776 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 25/802 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

21/805 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

11/89 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 3 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Taste disorder 87/1151 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 35/1188 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

35/1190 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

21/286 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 6 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

11/294 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 58/776 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 29/802 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

20/805 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

8/89 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 0 (0{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Dizziness 64/1151 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 61/1188 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 131/1190 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

19/286 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 15 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 31/294 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 39/776 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 38/802 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 90/805 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

6/89 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 8 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 10 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Chest pain 53/1147 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 86/1188 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

83/1190 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 15/287 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 23 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 19/294 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 34/772 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 59/802 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 54/805 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4/88 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 10 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Sore throat or difficult to swallow 45/1151 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 40/1188 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 64/1190 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 18/286 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 11 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 20/294 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 23/776 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 26/802 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 40/805 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4/89 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 3 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Skin rash 36/1151 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 50/1188 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 34/1190 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 11/286 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 13 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 6/294 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 21/776 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 35/802 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 25/805 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4/89 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 3 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Myalgia 31/1147 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 50/1188 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 88/1190 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

9/287 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 11 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 22/294 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 19/772 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 34/802 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 59/805 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

3/88 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 5 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Headache 20/1147 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 55/1188 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

81/1190 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

6/287 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 15 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 23/294 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

11/772 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 36/802 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

50/805 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

3/88 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 8 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Nausea or vomiting 17/1150 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 10/1188 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 27/1190 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

8/286 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 8/294 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 9/775 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4/802 (0{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 18/805 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

0/89 (0{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 1 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) mMRC dyspnoea score 0 816/1104 (74{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 834/1187 (70{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

1023/1191 (86{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

216/288 (75{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 222/294 (76{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 253 (86{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

551/734 (75{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 556/802 (69{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 694/805 (86{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

49/82 (60{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 56 (62{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 76 (84{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

≥1 288/1104 (26{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 353/1187 (30{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

168/1191 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

72/288 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 72/294 (24{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 42 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

183/734 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 246/802 (31{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 111/805 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

33/82 (40{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 35 (38{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 15 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

EQ-5D-5L

^§

Detailed results of EQ-5D-5L questionnaire of COVID-19 survivors are shown in the appendix (p 17); EQ-VAS scores range from 0–100, with higher scores indicating better health status.

Pain or discomfort 300/1104 (27{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 348/1187 (29{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 284/1191 (24{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

78/286 (27{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 78/294 (27{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 73 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 189/736 (26{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 240/802 (30{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 189/805 (23{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

33/82 (40{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 30 (33{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 22 (24{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Anxiety or depression 256/1105 (23{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 312/1187 (26{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 143/1191 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

70/288 (24{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 73/294 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 34 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

158/736 (21{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 213/802 (27{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

98/805 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

28/81 (35{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 26 (29{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 11 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

Mobility problem 68/1109 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 106/1187 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

42/1191 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

15/289 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 21/294 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 10 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 40/738 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 78/802 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 27/805 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

13/82 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 5 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Personal care problem 8/1109 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 17/1187 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 14/1191 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 0/289 (0{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 3/294 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 4 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7/738 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 11/802 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 8/805 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 1/82 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 3 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Usual activity problem 16/1100 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 14/1187 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 35/1191 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

3/288 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2/294 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 8 (3{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 10/731 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 10/802 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 20/805 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 3/81 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Utility index score

^¶

Utility index score: 1 indicates perfect health, 0 indicates death, and negative scores represent values as worse than death.

1·0 (0·9–1·0) 1·0 (0·9–1·0)

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

1·0 (0·9–1·0)

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

1·0 (0·9–1·0) 1·0 (0·9–1·0) 1·0 (0·9–1·0) 1·0 (0·9–1·0) 1·0 (0·9–1·0)

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

1·0 (0·9–1·0)

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

1·0 (0·9–1·0) 1·0 (0·9–1·0) 1·0 (0·9–1·0) EQ-VAS score 80·0 (75·0–90·0) 80·0 (70·0–90·0) 80·0 (70·0–90·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

80·0 (70·0–90·0) 80·0 (70·0–90·0) 80·0 (70·0–90·0) 80·0 (75·0–90·0) 80·0 (75·0–90·0)

*

p<4·17 × 10−3 for the comparison of 12-month with 6-month follow-up.

80·0 (70·0–90·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

80·0 (70·0–90·0) 80·0 (70·0–85·0) 80·0 (70·0–90·0) Distance walked in 6 min, m 495·0 (450·0–540·0) 495·0 (445·0–545·0) 512·0 (458·0–563·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

494·5 (450·0–540·0) 495·0 (440·0–540·0) 510·0 (455·0–564·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

496·0 (450·0–540·0) 495·0 (445·0–545·0) 510·0 (457·0–555·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

495·0 (430·0–528·0) 496·5 (455·0–551·0) 530·0 (480·0–600·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

Percentage of predicted value

^‖

Predicted values were calculated according to the method of Enright and Sherrill.

88·1 (79·7–96·2) 90·2 (81·6–98·8) 94·0 (84·7–104·1)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

86·9 (78·5–94·9) 89·6 (81·0–96·7) 93·8 (85·0–103·5)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

88·7 (80·5–97·1) 90·7 (82·6–100·2) 94·1 (84·6–104·0)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

83·6 (76·0–92·8) 87·9 (80·4–98·0) 95·0 (84·5–105·9)

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

^‡

p<4·17 × 10−3 for the comparison of 2-year with 12-month follow-up.

Less than LLN

**

The LLN was calculated by subtracting 153 m from the predicted value for men or by subtracting 139 m for women.

156/1105 (14{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 132/1167 (11{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 89/1065 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

45/287 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 36/286 (13{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 17/254 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

91/738 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 81/793 (10{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 65/726 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

20/80 (25{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 15/88 (17{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7/85 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})

^†

p<4·17 × 10−3 for the comparison of 2-year with 6-month follow-up.

Mental health Anxiety symptom (GAD-7≥5) NA NA 98/1187 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 26/294 (9{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 66/802 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 6 (7{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Depression symptom (PHQ-9≥5) NA NA 75/1190 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 25 (8{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 45/804 (6{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 5 (5{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) PTSD symptom (PCL-C ≥38) NA NA 27/1189 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 12 (4{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 14/803 (2{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA NA 1 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Health-care use Outpatient clinic visit NA 215/1169 (18{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 226/1187 (19{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 54/290 (19{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 56/294 (19{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 149/790 (19{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 150/803 (19{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 12/89 (13{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 20/90 (22{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Hospitalisation NA 152/1169 (13{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 159/1187 (13{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 38/290 (13{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 45/294 (15{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 100/790 (13{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 95/803 (12{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 14/89 (16{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 19/90 (21{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Emergency department visit NA 12/1169 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 7/1187 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 3/290 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 2/294 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 8/790 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 5/803 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 1/89 (1{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 0/90 (0{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) Returned to original work

This category only includes those who had a full-time or part-time job before COVID-19.

NA 401/455 (88{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 438/494 (89{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 99/115 (86{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 112/124 (90{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 268/300 (89{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 282/321 (88{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) NA 34/40 (85{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33}) 44/49 (90{44affb6c5789133b77de981cb308c1480316fee51f5fd5f1575b130f48379a33})